ArticleTechnical innovations & patient support in radiation oncology2026
Correction of image-guided radiotherapy and intrafraction motion using ExacTrac dynamic for head and neck cancer patients.
Article in Technical innovations & patient support in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Daily cone-beam computed tomography (CBCT) based image-guided radiotherapy (IGRT) with six degrees of freedom (6DOF) is standard for head and neck cancer. We retrospectively analyzed 669 sessions from 20 patients, using CBCT guided 6DOF couch corrections followed by ExacTrac Dynamic adjustments. Surface-guided radiotherapy (SGRT) continuously monitored intrafraction motion, triggering verification images and couch shifts when tolerances were exceeded. Pitch and roll deviations were linked to translational misalignments up to 3 mm. SGRT prompted repositioning in 100 sessions (15%), although nearly half of these movements were false positives. This demonstrates SGRT's value as a complementary, non-invasive tool for intrafraction monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.